R&D
Treating the chronic diseases GLP-1s miss, with Laurent Auda...
Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
News
Lilly strikes again, buying CAR-T firm Orna for $2.4bn
In its second major deal in two days, Eli Lilly has reached an agreement to buy in vivo CAR-T developer Orna Therapeutics for up to $2.4bn.
News
Data builds on Roche's dominance in primary progressive MS
Roche looks on track to add oral BTK inhibitor fenebrutinib to treatment options for primary progressive multiple sclerosis.
News
Novartis breaks ground on San Diego biomedical R&D site
Novartis has started construction of a $1.1bn biomedical research centre in San Diego that will serve as the hub for its R&D operations.
R&D
Changing Faces: Pharma and biotech, January 2026
The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
